ROWLAND LLOYD A - Insider Non-Derivative Transactions at CytomX Therapeutics, Inc. (CTMX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 20, 2024, ROWLAND LLOYD A's relationship to CytomX Therapeutics, Inc. (CTMX) is Officer (General Counsel), and currently has 134,978 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CTMX insiders.
Data Source: SEC.
ROWLAND LLOYD A - Insider Non-Derivative Transactions of CTMX Common Stock
ROWLAND LLOYD A - Insider Non-Derivative Transactions at CTMX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 21, 2024 | Sell -- (Common Stock) | 4181 | 1.23 | 130797 |
| Aug 21, 2024 | M -- (Common Stock) | 11250 | 0 | 134978 |
| Mar 20, 2024 | Sell -- (Common Stock) | 5268 | 2.09 | 117728 |
| Jan 19, 2024 | Acquisition -- (Common Stock) | 25000 | 0 | 122996 |
| Dec 21, 2023 | Sell -- (Common Stock) | 4077 | 1.38 | 97996 |
| Dec 18, 2023 | M -- (Common Stock) | 11250 | 0 | 102073 |
| Sep 23, 2023 | Sell -- (Common Stock) | 5486 | 1.3 | 80609 |
| Sep 21, 2023 | Acquisition -- (Common Stock) | 15000 | 0 | 86095 |
| Mar 17, 2023 | Sell -- (Common Stock) | 2037 | 1.98 | 71095 |
| Feb 3, 2023 | Acquisition -- (Common Stock) | 25000 | 0 | 73132 |